Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Online pharmacy...

    Online pharmacy Netmeds raises Rs 247 crore in Series C funding

    Written by Ruby Khatun Khatun Published On 2018-09-04T10:22:18+05:30  |  Updated On 16 Aug 2021 11:26 AM IST

    New Delhi: Netmeds, online pharmacy announced securing funding worth USD 35 million ( Rs 247 crore) from Daun Penh's investment holding and existing investors.


    Hailing the fresh funding, Pradeep Dadha, CEO and Founder Netmeds.com said the money would be used to ensure that the company "stayed the course" with regard to the extraordinary double-digit month-on-month growth it has enjoyed since inception.


    "Daun Penh was joined in the round by the existing investors Sistema Asia Fund, and Tanncam Investment. MAPE, the Indian investment bank which has been involved with Netmeds since inception teamed with co-arranger Cambodian Investment Management for this Series C funding round," added Dadha.


    "Netmeds team will use the new funds "to both increase awareness through marketing efforts as well as to enhance the customer experience, which means more stock, more FC's and expedited deliveries," he added.


    He iterated that the company fully expects, and are prepared to welcome millions of Indians as members of the Netmeds family.


    "These regulations are something that we and other stakeholders have worked hard on for more than 3 years. Their passage is a big win for many, but, the biggest winners are the people, who are now assured unrestricted access to affordable medicine, no matter where they are," added Dadha.


    "We were very impressed with Mr. Dadha's family legacy in healthcare and the idea of building a business that would not only succeed as a venture but would also improve lives. That has been our goal in Cambodia and we are proud to play a part in this, and excited about our expansion into one the world's largest and fastest growing economies," said Oknha ING Bun Hoaw, a recognized visionary business leader in Cambodia.


    "Netmeds continues to astonish on the upside with outstanding execution on plan and strategy and performance beyond expectations. I remain firmly confident and inspired by the management team and am pleased with the further financial commitment by Tanncam Investment," said Anthony Galliano, CEO Cambodian Investment Management.


    "We continue to believe in India as a huge and fast-growing market, in the online pharmacy business as one of the hottest sectors in Indian e-commerce, and in the strong founding team as an enabler for Netmeds' leadership in the space," said MD and Partner, Sistema Asia Fund Advisory, Kirill Kozhevnikov.

    Anthony GallianoCambodian Investment ManagementDaun PenhDaun Penh's investment holdingfundFund raisefund raisingfundingIndia ki PharmacyKirill KozhevnikovMAPENetmedsNetmeds.comOknha ING Bun HoawOnline PharmacyPradeep DadhaRaisesseries C funding
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok